Pia Clara Pafundi

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 624 citations

Life Sciences, Infectious Diseases, Microbiology +14

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)

Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi et al. · Allergy · 2023 · 148 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +14

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease

Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon et al. · Cardiovascular Diabetology · 2021 · 132 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Yaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar et al. · Clinical Infectious Diseases · 2018 · 126 citations

Life Sciences, Infectious Diseases, Microbiology +17

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact

Alfredo Caturano, Carlo Acierno, Riccardo Nevola et al. · Processes · 2021 · 105 citations · Full text

Veterinary Medicine, Biochemistry, Inflammation +16